TanjaBrankoPejovicMD
Obstetrics & Gynecology • Portland, ORGynecologic Oncology
Associate Professor of Obstetrics & Gynecology, Oregon Health & Sci University
Dr. Pejovic is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3181 SW Sam Jackson Park Rd
# L466
Portland, OR 97239Phone+1 503-449-7621
Education & Training
Yale-New Haven Medical CenterFellowship, Gynecologic Oncology, 2000 - 2003- Yale-New Haven Medical CenterResidency, Obstetrics and Gynecology, 1996 - 2000
University of Belgrade Faculty of MedicineClass of 1984
Certifications & Licensure
CA State Medical License 2012 - 2026
OR State Medical License 2003 - 2025
WA State Medical License 2004 - 2017
American Board of Obstetrics and Gynecology Obstetrics & Gynecology- American Board of Obstetrics and Gynecology Gynecologic Oncology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2011-2014
- America's Top Doctors for Cancer Castle Connolly, 2013
- Portland Monthly Magazine Castle Connolly, 2011
- Join now to see all
Clinical Trials
Publications & Presentations
PubMed
- 5 citationsDevelopment and Perspectives: Multifunctional Nucleic Acid Nanomedicines for Treatment of Gynecological Cancers.Tetiana Korzun, Abraham S Moses, Parham Diba, Ariana L Sattler, Brennan Olson
Small. 2024-10-01 - 8 citationsIntegrative multi-omics analyses to identify the genetic and functional mechanisms underlying ovarian cancer risk regions.Eileen O Dareng, Simon G Coetzee, Jonathan P Tyrer, Pei-Chen Peng, Will Rosenow
American Journal of Human Genetics. 2024-06-06 - Exceptional Response to Trastuzumab Deruxtecan in a Patient With Recurrent Ovarian Clear Cell Carcinoma With Human Epidermal Growth Factor Receptor 2 Expression.Ben L Kong, Jayne M Stommel, Jamie M Keck, David Kilburn, Aaron Streblow
JCO Precision Oncology. 2024-06-01
Journal Articles
- Proposal for a Risk-Based Categorization of Uterine CarcinosarcomaFrederick R Ueland, Esther Elishaev, Tanja Pejovic, Todd B Sheridan, Terry Morgan, Joseph L Kelley, Malcolm S Ross, Stephen H Bush, Ardeshir Hakam, Lynda D Roman, Meri..., Annals of Surgical Oncology
- A Transcriptome-Wide Association Study Among 97,898 Women to Identify Candidate Susceptibility Genes for Epithelial Ovarian Cancer RiskPatricia A Ganz, Amanda E Toland, Susan M Domchek, Tanja Pejovic, Clinical Cancer Research
- Variants in Genes Encoding Small GTPases and Association with Epithelial Ovarian Cancer SusceptibilityJulie M Cunningham, Robert P Edwards, Elizabeth M Poole, Tanja Pejovic, PLoS One
- Join now to see all
Press Mentions
Can a PARP Inhibitor plus Immunotherapy Improve Recurrent Ovarian Cancer Outcomes?June 25th, 2019
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
